ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 366

Serum Uric Acid Level and Subclinical Coronary Atherosclerosis in Asymptomatic Individuals: An Observational Cohort Study

Doo-Ho Lim1, Gyung-Min Park 2, Seung Won Choi 3, Su Jin Choi 4, So Hye Nam 5, Seokchan Hong 4, Yong-Gil Kim 4, Chang-Keun Lee 4 and Bin Yoo 4, 1Division of Rheumatology, Department of Internal Medicine, Ulsan University Hospital, Ulsan, Republic of Korea, 2Ulsan University hospital, Ulsan, Republic of Korea, 3Department of Internal Medicine, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Korea, Ulsan, Republic of Korea, 4Division of Rheumatology, Department of Internal Medicine, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea, 5Asan Medical Center, Seoul, Republic of Korea

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: computed tomography (CT) and atherosclerosis, coronary artery disease, hyperuricemia

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 10, 2019

Title: Metabolic & Crystal Arthropathies Poster I: Clinical

Session Type: Poster Session (Sunday)

Session Time: 9:00AM-11:00AM

Background/Purpose: High serum uric acid (SUA) level is the main prerequisite for gout, and it might be associated with obesity, hypertension, glucose intolerance, insulin resistance, and dyslipidemia which are the known risk factors for coronary artery disease. Although the association of SUA level with coronary artery disease has been investigated in previous studies, the results are conflicting. Further, there are limited data regarding the association between SUA and subclinical coronary atherosclerosis in asymptomatic individuals. This study investigated the influence of SUA level on subclinical coronary atherosclerosis, as detected by coronary computed tomography angiography (CCTA), in an asymptomatic population.

Methods: We evaluated 6,431 asymptomatic individuals with no prior history of coronary artery disease who voluntarily underwent laboratory tests and CCTA as part of a general health examination. The participants were stratified into quartiles according to their SUA levels (Figure). Coronary atherosclerotic plaques (calcified, mixed, and non-calcified plaques) were assessed using CCTA. Logistic regression analysis was used to determine the association between SUA levels and subclinical coronary atherosclerosis.

Results: Among the 6,431 individuals (mean age, 53.6 ± 7.6 years) in the study, 72.9% were male. The prevalence of any atherosclerotic, calcified, mixed, and non-calcified plaques increased with SUA quartiles (all p < 0.001) (Table 1). After adjustment for cardiovascular risk factors including age, sex, obesity, diabetes mellitus, hypertension, hyperlipidemia, current smoking status, family history of coronary artery disease, and high-sensitivity C-reactive protein ≥2 mg/L., there were no statistically significant differences in the adjusted odds ratios for calcified plaques (1.19; 95% confidence interval [CI] 0.98–1.45; p = 0.087) and mixed plaques (1.25; 95% CI 0.93–1.67; p = 0.139) in the fourth SUA quartile compared to the first quartile. However, the adjusted odds ratios for any atherosclerotic plaque (1.39; 95% CI 1.15–1.67; p = 0.001) and non-calcified plaque (1.38; 95% CI 1.11–1.71; p = 0.004) were significantly higher in the fourth SUA quartile (Table 2).

Conclusion: In asymptomatic individuals, high SUA level was an independent predictor of non-calcified plaques, suggesting an increased cardiovascular risk.


Disclosure: D. Lim, None; G. Park, None; S. Choi, None; S. Choi, None; S. Nam, None; S. Hong, None; Y. Kim, None; C. Lee, None; B. Yoo, None.

To cite this abstract in AMA style:

Lim D, Park G, Choi S, Choi S, Nam S, Hong S, Kim Y, Lee C, Yoo B. Serum Uric Acid Level and Subclinical Coronary Atherosclerosis in Asymptomatic Individuals: An Observational Cohort Study [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/serum-uric-acid-level-and-subclinical-coronary-atherosclerosis-in-asymptomatic-individuals-an-observational-cohort-study/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/serum-uric-acid-level-and-subclinical-coronary-atherosclerosis-in-asymptomatic-individuals-an-observational-cohort-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology